142 related articles for article (PubMed ID: 23648438)
1. Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma.
Okwan-Duodu D; Pollack BP; Lawson D; Khan MK
Am J Clin Oncol; 2015 Feb; 38(1):119-25. PubMed ID: 23648438
[TBL] [Abstract][Full Text] [Related]
2. Can radiation restore immunotherapy response in metastatic melanoma refractory to checkpoint inhibitors: An institutional experience in salvaging immunotherapy resistant disease.
Alhumaid M; Dinakaran D; Smylie M; Walker J; Joseph K
Radiother Oncol; 2023 Aug; 185():109712. PubMed ID: 37178931
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy Combined with Radiation in Malignant Melanoma without BRAF Mutations Brain Metastases-Favorable Response after Immunotherapy Continued beyond Progression.
Rahnea-Nita RA; Rebegea LF; Toma RV; Mocanu H; Soare I; Mihailov R; Nechifor A; Guliciuc M; Constantin GB; Rahnea-Nita G
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248787
[TBL] [Abstract][Full Text] [Related]
4. Intracranial response after extracranial radiation in a patient with rapidly progressing metastatic melanoma.
Piercey O; Tomaszewski JM; Smith K
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34088687
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis.
Agarwala SS; Hellstrand K; Gehlsen K; Naredi P
Cancer Immunol Immunother; 2004 Sep; 53(9):840-1. PubMed ID: 15127238
[No Abstract] [Full Text] [Related]
6. Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report.
Joe MB; Lum JJ; Watson PH; Tonseth RP; McGhie JP; Truong PT
J Gastrointest Oncol; 2017 Dec; 8(6):E84-E89. PubMed ID: 29299375
[TBL] [Abstract][Full Text] [Related]
7. Immune-Mediated Adverse Effects in the Immunotherapy Treatment of Patients With Metastatic Melanoma Versus Adjuvant Regimen: A Study in a Daily Practice Setting.
Martos-Cabrera L; Gallego T; Fernandez-Galván A; Rodríguez-Jiménez P
Actas Dermosifiliogr; 2024 Jan; 115(1):T97-T101. PubMed ID: 37838227
[No Abstract] [Full Text] [Related]
8. Immune-Mediated Adverse Effects in the Immunotherapy Treatment of Patients With Metastatic Melanoma Versus Adjuvant Regimen: A Study in a Daily Practice Setting.
Martos-Cabrera L; Gallego T; Fernandez-Galván A; Rodríguez-Jiménez P
Actas Dermosifiliogr; 2024 Jan; 115(1):97-101. PubMed ID: 37315686
[No Abstract] [Full Text] [Related]
9. Neoadjuvant immunotherapy improves outlook in high-risk melanoma.
Nierengarten MB
Cancer; 2023 Jul; 129(13):1952. PubMed ID: 37300812
[No Abstract] [Full Text] [Related]
10. The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent.
Jutzy JMS; Lemons JM; Luke JJ; Chmura SJ
Int J Breast Cancer; 2018; 2018():4786819. PubMed ID: 29862083
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Melanoma Metastatic to the Brain.
Turajlic S; Larkin J
N Engl J Med; 2018 Aug; 379(8):789-790. PubMed ID: 30134137
[No Abstract] [Full Text] [Related]
12. Case report: Immunotherapy inducing unexpected overall survival in choroidal melanoma: about a case.
Elhaitmy Y; El Anssari S; Fournel P; Mellas N; Bouleftour W; Lamuraglia M
Front Oncol; 2024; 14():1319792. PubMed ID: 38706606
[TBL] [Abstract][Full Text] [Related]
13. Pathology and Molecular Biology of Melanoma.
Timis T; Bergthorsson JT; Greiff V; Cenariu M; Cenariu D
Curr Issues Mol Biol; 2023 Jun; 45(7):5575-5597. PubMed ID: 37504268
[TBL] [Abstract][Full Text] [Related]
14. Body-mass index and metastatic melanoma outcomes.
Lennon H; Badrick E; Sperrin M; Renehan AG
Lancet Oncol; 2018 May; 19(5):e225. PubMed ID: 29726384
[No Abstract] [Full Text] [Related]
15. Improved survival outcomes for melanoma of unknown primary in the era of novel therapies: A population-based retrospective analysis.
Tupper CJ; Clausen MC; Cogua LM; Silberstein PT
J Am Acad Dermatol; 2024 Mar; ():. PubMed ID: 38458569
[No Abstract] [Full Text] [Related]
16. Combining Immunotherapy and Targeted Therapies With Cryotherapy in Patients With Cutaneous Metastatic Melanoma.
Akay BN; Aydemir AT
Dermatol Surg; 2024 Mar; ():. PubMed ID: 38535504
[No Abstract] [Full Text] [Related]
17. Locoregional melanoma: identifying optimal care in a rapidly changing landscape.
Gyorki DE; Zager JS
Melanoma Manag; 2019 Nov; 6(3):MMT22. PubMed ID: 31807273
[No Abstract] [Full Text] [Related]
18. Has the melanoma information tsunami become a maelstrom?
Thompson JF; Menzies AM
Melanoma Manag; 2017 Dec; 4(4):179-182. PubMed ID: 30190924
[No Abstract] [Full Text] [Related]
19. Diagnosis and Treatment of Intestinal Melanoma Metastases in the Era of Effective Systemic Treatment: Retraction.
Ann Surg; 2017 Sep; ():. PubMed ID: 28885512
[No Abstract] [Full Text] [Related]
20. A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab.
Chandra RA; Wilhite TJ; Balboni TA; Alexander BM; Spektor A; Ott PA; Ng AK; Hodi FS; Schoenfeld JD
Oncoimmunology; 2015 Nov; 4(11):e1046028. PubMed ID: 26451318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
